| microRNA | Survival analysis | Number of articles | Included references | HR | 95%CI | P value | Heterogeneity | Total patients | Figure | Publication bias |
| 10b | OS/DFS | 3 | [27–29] | 1.349 | 0.984-1.849 | 0.063 | 89.7%, p<0.001 | 550 | 4A | 0.16 | 15b | OS/DFS | 5 | [15, 16, 26, 28, 30] | 1.584 | 1.199-2.092 | 0.001 | 74.9%, p=0.001 | 640 | 2A | 0.263 | 17 | OS/DFS | 5 | [20, 26, 28, 31, 32] | 0.933 | 0.759-1.149 | 0.516 | 75.8%, p<0.001 | 1200 | 4B | 0.368 | 20a | OS/DFS | 4 | [20, 26, 28, 31] | 0.919 | 0.755-1.119 | 0.399 | 77.9%, p<0.001 | 1092 | 4C | 0.925 | 21 | OS/DFS | 6 | [18, 28, 30, 33–35] | 1.591 | 1.278-1.981 | <0.001 | 82.6%, p<0.001 | 1022 | 2B | 0.536 | 106a | OS/DFS | 6 | [20, 26, 28, 31, 34, 36] | 0.809 | 0.655-0.998 | 0.048 | 77.9%, p<0.001 | 1433 | 3A | 0.177 | 124 | OS/DFS | 3 | [26, 28, 37] | 0.833 | 0.729-0.952 | 0.007 | 66.6%, p=0.018 | 570 | 3B | 0.516 | 148a | OS/DFS | 3 | [28, 31, 38] | 1.122 | 1.023-1.231 | 0.015 | 60.5%, p=0.038 | 920 | 2C | 0.254 | 155 | OS/DFS | 4 | [28, 33, 39, 40] | 1.143 | 0.942-1.387 | 0.175 | 74.9%, p=0.001 | 1129 | 4D | 0.586 | 182 | OS | 4 | [26, 36, 41, 42] | 1.206 | 0.709-2.051 | 0.489 | 81%, p<0.001 | 554 | 4E | 0.955 | 196 | OS | 4 | [30, 36, 43, 44] | 1.877 | 1.033-3.411 | 0.039 | 77.5%, p=0.001 | 357 | 2D | 0.893 | 200b | OS | 3 | [31, 45, 46] | 1.113 | 0.451-2.744 | 0.816 | 77.5%, p=0.012 | 450 | 4F | 0.923 | 210 | OS/DFS | 5 | [28, 33, 40, 47, 48] | 1.251 | 1.010-1.550 | 0.04 | 84.7%, p<0.001 | 1249 | 2E | 0.181 | 221 | OS/DFS | 7 | [19, 20, 28, 31, 49–51] | 1.269 | 1.054-1.527 | 0.012 | 77.0%, p<0.001 | 1360 | 2F | 0.194 | 222 | OS/DFS | 7 | [19, 20, 26, 28, 31, 49, 50] | 1.104 | 0.907-1.343 | 0.325 | 83.5%, p<0.001 | 1301 | 4G | 0.765 |
|
|